These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 6311776

  • 1. Effectiveness of levamisole on herpetic ganglionic latency.
    Hiyama N, Sakata H, Yoshida H, Kondo H, Hirakawa Y.
    Hiroshima J Med Sci; 1983 Jun; 32(2):219-22. PubMed ID: 6311776
    [No Abstract] [Full Text] [Related]

  • 2. [Studies on the effectiveness of levamisole on mice experimental herpetic keratitis. 1. Inhibition of trigeminal ganglionic latency of herpes simplex virus].
    Hiyama N.
    Nippon Ganka Gakkai Zasshi; 1983 Jun; 87(5):346-51. PubMed ID: 6310977
    [No Abstract] [Full Text] [Related]

  • 3. [Latent infection of the regional sensory ganglion with herpes simplex virus (author's transl)].
    Rajcáni J.
    Bratisl Lek Listy; 1978 Oct; 70(4):520-8. PubMed ID: 214212
    [No Abstract] [Full Text] [Related]

  • 4. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse.
    Tullo AB, Shimeld C, Blyth WA, Hill TJ, Easty DL.
    J Gen Virol; 1982 Nov; 63 (Pt 1)():95-101. PubMed ID: 6294236
    [Abstract] [Full Text] [Related]

  • 5. Co-cultivation versus blot hybridization for the detection of trigeminal ganglionic latency following corneal inoculation with HSV-1 strains of varying TK expression and pathogenicity.
    Gordon YJ, Rock DL.
    Curr Eye Res; 1984 Sep; 3(9):1097-100. PubMed ID: 6092001
    [Abstract] [Full Text] [Related]

  • 6. [Infection in trigeminal ganglia following experimental herpetic keratitis (author's transl)].
    Kajiwara K.
    Nippon Ganka Gakkai Zasshi; 1979 Aug 10; 83(8):1055-9. PubMed ID: 230733
    [No Abstract] [Full Text] [Related]

  • 7. Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2.
    Tenser RB, Jones JC, Ressel SJ.
    J Infect Dis; 1985 Mar 10; 151(3):548-50. PubMed ID: 2982968
    [No Abstract] [Full Text] [Related]

  • 8. Effect of experimental herpes simplex virus vaccine on established ganglionic latency.
    Ohashi Y, Sugano T, Kato S, Sato K.
    Jpn J Ophthalmol; 1982 Mar 10; 26(1):18-22. PubMed ID: 6287066
    [Abstract] [Full Text] [Related]

  • 9. In vivo reactivation of herpes simplex virus in rabbit trigeminal ganglia: electrode model.
    Green MT, Rosborough JP, Dunkel EC.
    Infect Immun; 1981 Oct 10; 34(1):69-74. PubMed ID: 6271686
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of levamisole on stromal herpetic keratitis.
    Sakata H, Yoshida H, Hiyama N, Kondo H, Hirakawa Y.
    Hiroshima J Med Sci; 1983 Dec 10; 32(4):555-9. PubMed ID: 6678909
    [No Abstract] [Full Text] [Related]

  • 11. [Prophylaxis of herpes simplex virus type 1 infection on guinea pig corneas by detergent-soluble extract (DSE) of virus-infected cells: inhibitory effect of DSE on the establishment of trigeminal ganglionic latency (author's transl)].
    Ohashi Y, Kato S, Sato K, Hara J, Danjo S, Kinoshita S, Sasabe T, Shimomura Y.
    Nippon Ganka Gakkai Zasshi; 1980 Sep 10; 84(9):1051-55. PubMed ID: 6971568
    [No Abstract] [Full Text] [Related]

  • 12. Lack of levamisole effect on experimental herpes keratitis.
    Kaufman HE, Varnell ED.
    Invest Ophthalmol Vis Sci; 1977 Dec 10; 16(12):1148-50. PubMed ID: 924745
    [Abstract] [Full Text] [Related]

  • 13. Herpes simplex virus latency in the rabbit trigeminal ganglia: ganglionic superinfection.
    Centifanto-Fitzgerald YM, Rayfield M, Tian PY, Kaufman HE.
    Proc Soc Exp Biol Med; 1985 May 10; 179(1):55-67. PubMed ID: 2986150
    [Abstract] [Full Text] [Related]

  • 14. Herpesvirus in sensory and autonomic ganglia after eye infection.
    Martin RG, Dawson CR, Jones P, Togni B, Lyons C, Oh JO.
    Arch Ophthalmol; 1977 Nov 10; 95(11):2053-6. PubMed ID: 200208
    [Abstract] [Full Text] [Related]

  • 15. Treatment of herpes simplex keratitis with levamisole.
    Smolin G, Okumoto M, Friedlaender M.
    Arch Ophthalmol; 1978 Jun 10; 96(6):1078-81. PubMed ID: 207250
    [Abstract] [Full Text] [Related]

  • 16. Ocular herpes simplex and the establishment of latent infection.
    Tullo AB, Easty DL, Hill TJ, Blyth WA.
    Trans Ophthalmol Soc U K (1962); 1982 Apr 10; 102 (Pt 1)():15-8. PubMed ID: 6301114
    [Abstract] [Full Text] [Related]

  • 17. Spread of herpes simplex virus and distribution of latent infection after intraocular infection of the mouse.
    Shimeld C, Tullo AB, Hill TJ, Blyth WA, Easty DL.
    Arch Virol; 1985 Apr 10; 85(3-4):175-87. PubMed ID: 2992417
    [Abstract] [Full Text] [Related]

  • 18. Herpetic ganglionic latency. Aciclovir and vidarabine therapy.
    Pavan-Langston D, Park NH, Lass JH.
    Arch Ophthalmol; 1979 Aug 10; 97(8):1508-10. PubMed ID: 223531
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of simple recurrent herpetic parenchymatous keratitis with levamisole].
    Zhu SP.
    Zhonghua Yan Ke Za Zhi; 1985 Sep 10; 21(5):265-7. PubMed ID: 3937698
    [No Abstract] [Full Text] [Related]

  • 20. Protective immunity against herpetic ocular disease in an outbred mouse model.
    Metcalf JF, Whitley RJ.
    Curr Eye Res; 1987 Jan 10; 6(1):167-71. PubMed ID: 3030641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.